STACIA SHEA: Open Payments
NPI 1548397243 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,593 in 64 payments from 31 companies in 2025. Trend: 2023 $386 · 2024 $788 · 2025 $1,593
Food & beverage: $1,503Education: $90
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $162 |
| AstraZeneca Pharmaceuticals LP | 6 | $148 |
| Incyte Corporation | 4 | $100 |
| E.R. Squibb & Sons, L.L.C. | 4 | $89 |
| Eisai Inc. | 4 | $87 |
| PFIZER INC. | 4 | $79 |
| Celgene Corporation | 3 | $77 |
| GlaxoSmithKline, LLC. | 3 | $76 |
| Deciphera Pharmaceuticals Inc. | 3 | $71 |
| Merck Sharp & Dohme LLC | 2 | $66 |
Products named: ERLEADA, Lenvima, REBLOZYL, QINLOCK, JEMPERLI, MONJUVI, JAKAFI, ZYNLONTA.
Industry payments across GA — which companies pay providers there.
